Neuropeptiid Y (Estonian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Neuropeptiid Y" in Estonian language version.

refsWebsite
Global rank Estonian rank
4th place
14th place
2nd place
16th place
low place
low place
1st place
1st place
14th place
56th place
low place
low place
5,293rd place
1,749th place
low place
3,004th place
149th place
130th place
low place
low place
5,479th place
8,671st place
6,663rd place
8,357th place
274th place
191st place
low place
low place
low place
low place

archive.today

aspetjournals.org

pharmrev.aspetjournals.org

  • Michel MC, Beck-Sickinger A, Cox H, Doods HN, Herzog H, Larhammar D, Quirion R, Schwartz T, Westfall T (March 1998). "XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors" http://pharmrev.aspetjournals.org/content/50/1/143.long Read 143–150 Kasutatud 05.10.2014

bentham-direct.org

buecher.de

bilder.buecher.de

doi.org

  • Allen YS, Adrian TE, Allen JM, Tatemoto K, Crow TJ, Bloom SR, Polak JM (august 1983). "Neuropeptide Y distribution in the rat brain". Science. 221 (4613): 877–9. DOI:10.1126/science.6136091. PMID 6136091.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link) Kasutatud 05.10.2014
  • Morris BJ (detsember 1989). "Neuronal localisation of neuropeptide Y gene expression in rat brain". J. Comp. Neurol. 290 (3): 358–68. DOI:10.1002/cne.902900305. PMID 2592617. Kasutatud 05.10.2014
  • Haas DA, George SR (oktoober 1989). "Neuropeptide Y-induced effects on hypothalamic corticotropin-releasing factor content and release are dependent on noradrenergic/adrenergic neurotransmission". Brain Res. 498 (2): 333–8. DOI:10.1016/0006-8993(89)91112-8. PMID 2551461. Kasutatud 05.10.2014
  • Edwardson JA, Hough CA (aprill 1975). "The pituitary-adrenal system of the genetically obese (ob/ob) mouse". J. Endocrinol. 65 (1): 99–107. DOI:10.1677/joe.0.0650099. PMID 167093. Kasutatud 05.10.2014
  • Dryden S, Pickavance L, Frankish HM, Williams G (september 1995). "Increased neuropeptide Y secretion in the hypothalamic paraventricular nucleus of obese (fa/fa) Zucker rats". Brain Res. 690 (2): 185–8. DOI:10.1016/0006-8993(95)00628-4. PMID 8535835.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link) Kasutatud 05.10.2014
  • Yukimura Y, Bray GA (1978). "Effects of adrenalectomy on body weight and the size and number of fat cells in the Zucker (fatty) rat". Endocr Res Commun. 5 (3): 189–98. DOI:10.1080/07435807809083752. PMID 747998. Kasutatud 05.10.2014
  • Hanson ES, Dallman MF (aprill 1995). "Neuropeptide Y (NPY) may integrate responses of hypothalamic feeding systems and the hypothalamo-pituitary-adrenal axis". J. Neuroendocrinol. 7 (4): 273–9. DOI:10.1111/j.1365-2826.1995.tb00757.x. PMID 7647769. Kasutatud 05.10.2014
  • Kuo LE, Kitlinska JB, Tilan JU; et al. (juuli 2007). "Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome". Nat. Med. 13 (7): 803–11. DOI:10.1038/nm1611. PMID 17603492. {{cite journal}}: et al.-i üleliigne kasutus kohas: |author= (juhend)CS1 hooldus: mitu nime: autorite loend (link) Kasutatud 05.10.2014
  • Yehuda R, Brand S, Yang RK (aprill 2006). "Plasma neuropeptide Y concentrations in combat exposed veterans: relationship to trauma exposure, recovery from PTSD, and coping". Biol. Psychiatry. 59 (7): 660–3. DOI:10.1016/j.biopsych.2005.08.027. PMID 16325152.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link) Kasutatud 05.10.2014
  • Larhammar D, Salaneck E (2004). "Molecular evolution of NPY receptor subtypes". Neuropeptides. 38 (4): 141–51. DOI:10.1016/j.npep.2004.06.002. PMID 15337367. Kasutatud 05.10.2014
  • Kamiji MM, Inui A (oktoober 2007). "Neuropeptide y receptor selective ligands in the treatment of obesity". Endocrine Reviews. 28 (6): 664–84. DOI:10.1210/er.2007-0003. PMID 17785427. Kasutatud 05.10.2014
  • MacNeil DJ (2007). "NPY Y1 and Y5 receptor selective antagonists as anti-obesity drugs". Current Topics in Medicinal Chemistry. 7 (17): 1721–33. DOI:10.2174/156802607782341028. PMID 17979781. Originaali arhiivikoopia seisuga 12. jaanuar 2013. Vaadatud 26. oktoobril 2014. Kasutatud 05.10.2014
  • Kamiji MM, Inui A (2007). "NPY Y2 and Y4 receptors selective ligands: promising anti-obesity drugs?". Current Topics in Medicinal Chemistry. 7 (17): 1734–42. DOI:10.2174/156802607782340957. PMID 17979782. Originaali arhiivikoopia seisuga 14. aprill 2013. Vaadatud 26. oktoobril 2014. Kasutatud 05.10.2014

jneurosci.org

neuropeptidesjournal.com

newsdaily.com

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Allen YS, Adrian TE, Allen JM, Tatemoto K, Crow TJ, Bloom SR, Polak JM (august 1983). "Neuropeptide Y distribution in the rat brain". Science. 221 (4613): 877–9. DOI:10.1126/science.6136091. PMID 6136091.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link) Kasutatud 05.10.2014
  • Morris BJ (detsember 1989). "Neuronal localisation of neuropeptide Y gene expression in rat brain". J. Comp. Neurol. 290 (3): 358–68. DOI:10.1002/cne.902900305. PMID 2592617. Kasutatud 05.10.2014
  • Haas DA, George SR (oktoober 1989). "Neuropeptide Y-induced effects on hypothalamic corticotropin-releasing factor content and release are dependent on noradrenergic/adrenergic neurotransmission". Brain Res. 498 (2): 333–8. DOI:10.1016/0006-8993(89)91112-8. PMID 2551461. Kasutatud 05.10.2014
  • Edwardson JA, Hough CA (aprill 1975). "The pituitary-adrenal system of the genetically obese (ob/ob) mouse". J. Endocrinol. 65 (1): 99–107. DOI:10.1677/joe.0.0650099. PMID 167093. Kasutatud 05.10.2014
  • Dryden S, Pickavance L, Frankish HM, Williams G (september 1995). "Increased neuropeptide Y secretion in the hypothalamic paraventricular nucleus of obese (fa/fa) Zucker rats". Brain Res. 690 (2): 185–8. DOI:10.1016/0006-8993(95)00628-4. PMID 8535835.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link) Kasutatud 05.10.2014
  • Wilcox G (mai 2005). "Insulin and insulin resistance". Clin Biochem Rev. 26 (2): 19–39. PMC 1204764. PMID 16278749. Kasutatud 05.10.2014
  • Yukimura Y, Bray GA (1978). "Effects of adrenalectomy on body weight and the size and number of fat cells in the Zucker (fatty) rat". Endocr Res Commun. 5 (3): 189–98. DOI:10.1080/07435807809083752. PMID 747998. Kasutatud 05.10.2014
  • Powley TL, Morton SA (1. aprill 1976). "Hypophysectomy and regulation of body weight in the genetically obese Zucker rat". Am. J. Physiol. 230 (4): 982–7. PMID 1267030. Originaali arhiivikoopia seisuga 10. veebruar 2009. Vaadatud 26. oktoobril 2014. Kasutatud 05.10.2014
  • Hanson ES, Dallman MF (aprill 1995). "Neuropeptide Y (NPY) may integrate responses of hypothalamic feeding systems and the hypothalamo-pituitary-adrenal axis". J. Neuroendocrinol. 7 (4): 273–9. DOI:10.1111/j.1365-2826.1995.tb00757.x. PMID 7647769. Kasutatud 05.10.2014
  • White BD, Dean RG, Edwards GL, Martin RJ (mai 1994). "Type II corticosteroid receptor stimulation increases NPY gene expression in basomedial hypothalamus of rats". Am. J. Physiol. 266 (5 Pt 2): R1523–9. PMID 8203629.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)[alaline kõdulink] Kasutatud 05.10.2014
  • Pomonis JD, Levine AS, Billington CJ (1. juuli 1997). "Interaction of the hypothalamic paraventricular nucleus and central nucleus of the amygdala in naloxone blockade of neuropeptide Y-induced feeding revealed by c-fos expression". J. Neurosci. 17 (13): 5175–82. PMID 9185555.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link) Kasutatud 05.10.2014
  • Kuo LE, Kitlinska JB, Tilan JU; et al. (juuli 2007). "Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome". Nat. Med. 13 (7): 803–11. DOI:10.1038/nm1611. PMID 17603492. {{cite journal}}: et al.-i üleliigne kasutus kohas: |author= (juhend)CS1 hooldus: mitu nime: autorite loend (link) Kasutatud 05.10.2014
  • Yehuda R, Brand S, Yang RK (aprill 2006). "Plasma neuropeptide Y concentrations in combat exposed veterans: relationship to trauma exposure, recovery from PTSD, and coping". Biol. Psychiatry. 59 (7): 660–3. DOI:10.1016/j.biopsych.2005.08.027. PMID 16325152.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link) Kasutatud 05.10.2014
  • Thiele TE, Koh MT, Pedrazzini T (veebruar 2002). "Voluntary alcohol consumption is controlled via the neuropeptide Y Y1 receptor". J. Neurosci. 22 (3): RC208. PMID 11826154.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link) Kasutatud 05.10.2014
  • Larhammar D, Salaneck E (2004). "Molecular evolution of NPY receptor subtypes". Neuropeptides. 38 (4): 141–51. DOI:10.1016/j.npep.2004.06.002. PMID 15337367. Kasutatud 05.10.2014
  • Kamiji MM, Inui A (oktoober 2007). "Neuropeptide y receptor selective ligands in the treatment of obesity". Endocrine Reviews. 28 (6): 664–84. DOI:10.1210/er.2007-0003. PMID 17785427. Kasutatud 05.10.2014
  • MacNeil DJ (2007). "NPY Y1 and Y5 receptor selective antagonists as anti-obesity drugs". Current Topics in Medicinal Chemistry. 7 (17): 1721–33. DOI:10.2174/156802607782341028. PMID 17979781. Originaali arhiivikoopia seisuga 12. jaanuar 2013. Vaadatud 26. oktoobril 2014. Kasutatud 05.10.2014
  • Kamiji MM, Inui A (2007). "NPY Y2 and Y4 receptors selective ligands: promising anti-obesity drugs?". Current Topics in Medicinal Chemistry. 7 (17): 1734–42. DOI:10.2174/156802607782340957. PMID 17979782. Originaali arhiivikoopia seisuga 14. aprill 2013. Vaadatud 26. oktoobril 2014. Kasutatud 05.10.2014

ncbi.nlm.nih.gov

nutritionjrnl.com

physiology.org

ajplegacy.physiology.org

ajpregu.physiology.org

sciencedirect.com

springer.com

link.springer.com

ucsf.edu

web.archive.org